Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc clinical trials

Explore recruiting adult patients with resectable muscle invasive urothelial cancer of the bladder defined as stage ii and iiia uc who have not yet undergone systemic therapy for ubc clinical trials.

Also recruiting in Europe

Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2 trial in stage II-IIIa urothelial cancer randomizing pre-operative nivolumab with or without relatlimab - TURANDORELA

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc trials by city

Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Toronto Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Vancouver Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Montreal Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Calgary Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Edmonton Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Ottawa Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Winnipeg Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Quebec City Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Hamilton Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Kitchener Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in London Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Halifax Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in New York Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Los Angeles Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Chicago Adult Patients With Resectable Muscle Invasive Urothelial Cancer Of The Bladder Defined As Stage Ii And Iiia Uc Who Have Not Yet Undergone Systemic Therapy For Ubc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease